About Peripheral Vascular Devices
Peripheral vascular disease is a condition characterized by damage to or blockage in the peripheral blood vessels. This disease may result in the form of blood clots such as deep vein thrombosis, inflammation, or narrowing and blockage of the blood vessels. In case the peripheral vascular disease affects only the arteries, the condition is known as PAD. PAD is also considered one of the most serious complications in patients with diabetes. It is characterized by narrowed arteries due to the accumulation of plaques (composed of fat, cholesterol, and fibrous tissue) that results in reduced blood flow to the brain, organs, and limbs, especially the legs. PAD is known to increase the risk of stroke and heart attack by up to six times. The devices used for the treatment of peripheral vascular disease include stents, balloon catheters, CTO, atherectomy devices, venacava filters, and grafts.
Technavio's analysts forecast the global peripheral vascular devices market to grow at a CAGR of 7.29% over the period 2014-2019.
Covered in this Report
The global peripheral vascular devices market is divided into six segments: peripheral vascular stents, PTA balloon catheters, aortic stent grafts, atherectomy devices, embolic protection devices, and others (synthetic surgical grafts, chronic total occlusion devices, inferior vena cava filters, and PTA guidewires).
Technavio's report, the Global Peripheral Vascular Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it also covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Abbott Laboratories
• Boston Scientific
• C.R. Bard
• Cordis
• Medtronic
Other Prominent Vendors
• AngioScore
• Angiodynamics
• Aptus Endosystems
• Argon Medical Devices
• Bolton Medical
• Cook Medical
• Endologix
• JOTEC
• LeMaitre Vascular
• Lombard Medical Technologies
• Terumo
• Teleflex
• TriVascular Technologies
• Volcano
• W.L. Gore
Market Driver
• Increase in incidence of peripheral vascular disease
• For a full, detailed list, view our report
Market Challenge
• Highly fragmented market
• For a full, detailed list, view our report
Market Trend
• Growing use of bio-absorbable stents
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Product
07.1 Global Peripheral Vascular Stents Market
07.1.1 Market Size and Forecast
07.1.2 Market Segmentation
07.2 Global PTA Balloon Catheters Market
07.2.1 Market Size and Forecast
07.2.2 Market Segmentation
07.3 Global Aortic Stent Grafts Market
07.3.1 Market Size and Forecast
07.3.2 Market Segmentation
07.4 Global Atherectomy Devices Market
07.4.1 Market Size and Forecast
07.4.2 Market Segmentation
07.5 Global Embolic Protection Devices Market
07.5.1 Market Size and Forecast
07.5.2 Market Segmentation
08. Global Expenditure on Medical Devices and Reimbursements
08.1.1 Expenditure on Medical Devices in Major OECD Countries 2013
08.1.2 Reimbursement Scenario
09. Geographical Segmentation
09.1 Peripheral Vascular Devices Market in Americas
09.1.1 Market Size and Forecast
09.2 Peripheral Vascular Devices Market in EMEA
09.2.1 Market Size and Forecast
09.3 Peripheral Vascular Devices Market in APAC
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and Their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and Their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Acquisitions
17.2 Vendor Analysis 2014
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Abbott Laboratories
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Business Segmentation
18.1.4 Business Strategy
18.1.5 Business Segmentation by Revenue 2012
18.1.6 Business Segmentation by Revenue 2011 and 2012
18.1.7 Geographical Segmentation by Revenue 2012
18.1.8 Key Information
18.1.9 SWOT Analysis
18.2 Boston Scientific
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Key Products
18.2.4 Key Products in Cardiovascular Segment
18.2.5 Key Products in MedSurg Segment
18.2.6 Key Products in Rhythm Management Segment
18.2.7 Business Segmentation by Revenue 2013
18.2.8 Business Segmentation by Revenue 2012 and 2013
18.2.9 Geographical Segmentation by Revenue 2013
18.2.10 Business Strategy
18.2.11 Recent Developments
18.2.12 SWOT Analysis
18.3 C. R. Bard
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Product Segmentation by Revenue 2013
18.3.4 Product Segmentation by Revenue 2012 and 2013
18.3.5 Geographical Segmentation by Revenue 2013
18.3.6 Business Strategy
18.3.7 Recent Developments
18.3.8 SWOT Analysis
18.4 Cordis
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation
18.4.4 Business Strategy
18.4.5 Recent Developments
18.4.6 SWOT Analysis
18.5 Medtronic
18.5.1 Key Facts
18.5.2 Business Overview
18.5.3 Key Products
18.5.4 Business Segmentation by Revenue 2014
18.5.5 Cardiac and Vascular Group Segmentation by Revenue 2014
18.5.6 Restorative Therapies Group Segmentation by Revenue 2014
18.5.7 Diabetes Group Segmentation by Revenue 2014
18.5.8 Business Segmentation by Revenue 2013 and 2014
18.5.9 Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014
18.5.10 Restorative Therapies Group Segmentation by Revenue 2013 and 2014
18.5.11 Diabetes Group Segmentation by Revenue 2013 and 2014
18.5.12 Geographical Segmentation by Revenue 2014
18.5.13 Business Strategy
18.5.14 Key Developments
18.5.15 SWOT Analysis
19. Other Reports in This Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Peripheral Vascular Devices Market 2014-2019 ($ millions)
Exhibit 3: Segmentation of Global Peripheral Vascular Devices Market by Product
Exhibit 4: Segmentation of Global Peripheral Vascular Devices Market by Product 2014
Exhibit 5: Global Peripheral Vascular Stents Market 2014-2019 ($ billions)
Exhibit 6: Segmentation of Global Peripheral Vascular Stents Market by Vessel Type
Exhibit 7: Global PTA Balloon Catheters Market 2014-2019 ($ millions)
Exhibit 8: Segmentation of Global PTA Balloon Catheters Market by Product Type
Exhibit 9: Global Aortic Stent Grafts Market 2014-2019 ($ millions)
Exhibit 10: Segmentation of Global Aortic Stents Market by Indication
Exhibit 11: Global Atherectomy Devices Market 2014-2019 ($ millions)
Exhibit 12: Segmentation of Global Atherectomy Devices Market
Exhibit 13: Global Embolic Protection Devices Market 2014-2019 ($ millions)
Exhibit 14: Segmentation of Global Embolic Protection Devices Market
Exhibit 15: Global Peripheral Vascular Devices Market 2014-2019
Exhibit 16: Medical Devices Spending Per Capita (% of GDP) in Major OECD Countries 2013 ($)
Exhibit 17: Segmentation of Global Peripheral Vascular Devices Market by Geography 2014
Exhibit 18: Peripheral Vascular Devices Market in Americas 2014-2019 ($ millions)
Exhibit 19: Peripheral Vascular Devices Market in EMEA 2014-2019 ($ millions)
Exhibit 20: Peripheral Vascular Devices Market in APAC 2014-2019 ($ millions)
Exhibit 21: Segmentation of Peripheral Vascular Devices Market by Geography 2014-2019
Exhibit 22: Abbott Laboratories: Business Segmentation
Exhibit 23: Abbott Laboratories: Business Segmentation by Revenue 2012
Exhibit 24: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 ($ Millions)
Exhibit 25: Abbott Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 26: Boston Scientific: Key Products in Cardiovascular Segment
Exhibit 27: Boston Scientific: Key Products in MedSurg Segment
Exhibit 28: Boston Scientific: Key Products in Rhythm Management Segment
Exhibit 29: Boston Scientific: Business Segmentation by Revenue 2013
Exhibit 30: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 ($ Millions)
Exhibit 31: Boston Scientific: Geographical Segmentation by Revenue 2013
Exhibit 32: C. R. Bard: Product Segmentation by Revenue 2013
Exhibit 33: C. R. Bard: Product Segmentation by Revenue 2012 and 2013 ($ Millions)
Exhibit 34: C. R. Bard: Geographical Segmentation by Revenue 2013
Exhibit 35: Cordis: Business Segmentation 2013
Exhibit 36: Medtronic: Business Segmentation by Revenue 2014
Exhibit 37: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2014
Exhibit 38: Medtronic: Restorative Therapies Group Segmentation by Revenue 2014
Exhibit 39: Medtronic: Diabetes Group Segmentation by Revenue 2014
Exhibit 40: Medtronic: Business Segmentation by Revenue 2013 and 2014 ($ Millions)
Exhibit 41: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014 ($ Millions)
Exhibit 42: Medtronic: Restorative Therapies Group Segmentation by Revenue 2013 and 2014 ($ Millions)
Exhibit 43: Medtronic: Diabetes Group Segmentation by Revenue 2013 and 2014 ($ Millions)
Exhibit 44: Medtronic: Geographical Segmentation by Revenue 2014
